Nmnat mitigates sensory dysfunction in a Drosophila model of paclitaxel-induced peripheral neuropathy

Jennifer M. Brazill, Beverley Cruz, Yi Zhu, Rong G Zhai

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Chemotherapy-induced peripheral neuropathy (CIPN) is the major dose-limiting side effect of many commonly used chemotherapeutic agents, including paclitaxel. Currently, there are no neuroprotective or effective symptomatic treatments for CIPN. Lack of understanding of the in vivo mechanisms of CIPN has greatly impeded the identification of therapeutic targets. Here, we optimized a model of paclitaxel-induced peripheral neuropathy using Drosophila larvae that recapitulates aspects of chemotherapy-induced sensory dysfunction. We showed that nociceptive sensitivity is associated with disrupted organization of microtubule-associated MAP1B/Futsch and aberrant stabilization of peripheral sensory dendrites. These findings establish a robust and amenable model for studying peripheral mechanisms of CIPN. Using this model,we uncovered a critical role for nicotinamide mononucleotide adenylyltransferase (Nmnat) in maintaining the integrity and function of peripheral sensory neurons and uncovered Nmnat's therapeutic potential against diverse sensory symptoms of CIPN.

Original languageEnglish (US)
Article numberdmm.032938
JournalDMM Disease Models and Mechanisms
Volume11
Issue number6
DOIs
StatePublished - Jun 1 2018

Fingerprint

Nicotinamide-Nucleotide Adenylyltransferase
Chemotherapy
Peripheral Nervous System Diseases
Paclitaxel
Drosophila
Drug Therapy
Sensory Receptor Cells
Dendrites
Microtubules
Neurons
Larva
Therapeutics
Stabilization

Keywords

  • Chemotherapy
  • Microtubules
  • Neuropathy
  • Neuroprotection
  • Nmnat
  • Paclitaxel

ASJC Scopus subject areas

  • Neuroscience (miscellaneous)
  • Medicine (miscellaneous)
  • Immunology and Microbiology (miscellaneous)
  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Nmnat mitigates sensory dysfunction in a Drosophila model of paclitaxel-induced peripheral neuropathy. / Brazill, Jennifer M.; Cruz, Beverley; Zhu, Yi; Zhai, Rong G.

In: DMM Disease Models and Mechanisms, Vol. 11, No. 6, dmm.032938, 01.06.2018.

Research output: Contribution to journalArticle

@article{ce77582473624e4db2b1bccf2410e1bc,
title = "Nmnat mitigates sensory dysfunction in a Drosophila model of paclitaxel-induced peripheral neuropathy",
abstract = "Chemotherapy-induced peripheral neuropathy (CIPN) is the major dose-limiting side effect of many commonly used chemotherapeutic agents, including paclitaxel. Currently, there are no neuroprotective or effective symptomatic treatments for CIPN. Lack of understanding of the in vivo mechanisms of CIPN has greatly impeded the identification of therapeutic targets. Here, we optimized a model of paclitaxel-induced peripheral neuropathy using Drosophila larvae that recapitulates aspects of chemotherapy-induced sensory dysfunction. We showed that nociceptive sensitivity is associated with disrupted organization of microtubule-associated MAP1B/Futsch and aberrant stabilization of peripheral sensory dendrites. These findings establish a robust and amenable model for studying peripheral mechanisms of CIPN. Using this model,we uncovered a critical role for nicotinamide mononucleotide adenylyltransferase (Nmnat) in maintaining the integrity and function of peripheral sensory neurons and uncovered Nmnat's therapeutic potential against diverse sensory symptoms of CIPN.",
keywords = "Chemotherapy, Microtubules, Neuropathy, Neuroprotection, Nmnat, Paclitaxel",
author = "Brazill, {Jennifer M.} and Beverley Cruz and Yi Zhu and Zhai, {Rong G}",
year = "2018",
month = "6",
day = "1",
doi = "10.1242/dmm.032938",
language = "English (US)",
volume = "11",
journal = "DMM Disease Models and Mechanisms",
issn = "1754-8403",
publisher = "Company of Biologists Ltd",
number = "6",

}

TY - JOUR

T1 - Nmnat mitigates sensory dysfunction in a Drosophila model of paclitaxel-induced peripheral neuropathy

AU - Brazill, Jennifer M.

AU - Cruz, Beverley

AU - Zhu, Yi

AU - Zhai, Rong G

PY - 2018/6/1

Y1 - 2018/6/1

N2 - Chemotherapy-induced peripheral neuropathy (CIPN) is the major dose-limiting side effect of many commonly used chemotherapeutic agents, including paclitaxel. Currently, there are no neuroprotective or effective symptomatic treatments for CIPN. Lack of understanding of the in vivo mechanisms of CIPN has greatly impeded the identification of therapeutic targets. Here, we optimized a model of paclitaxel-induced peripheral neuropathy using Drosophila larvae that recapitulates aspects of chemotherapy-induced sensory dysfunction. We showed that nociceptive sensitivity is associated with disrupted organization of microtubule-associated MAP1B/Futsch and aberrant stabilization of peripheral sensory dendrites. These findings establish a robust and amenable model for studying peripheral mechanisms of CIPN. Using this model,we uncovered a critical role for nicotinamide mononucleotide adenylyltransferase (Nmnat) in maintaining the integrity and function of peripheral sensory neurons and uncovered Nmnat's therapeutic potential against diverse sensory symptoms of CIPN.

AB - Chemotherapy-induced peripheral neuropathy (CIPN) is the major dose-limiting side effect of many commonly used chemotherapeutic agents, including paclitaxel. Currently, there are no neuroprotective or effective symptomatic treatments for CIPN. Lack of understanding of the in vivo mechanisms of CIPN has greatly impeded the identification of therapeutic targets. Here, we optimized a model of paclitaxel-induced peripheral neuropathy using Drosophila larvae that recapitulates aspects of chemotherapy-induced sensory dysfunction. We showed that nociceptive sensitivity is associated with disrupted organization of microtubule-associated MAP1B/Futsch and aberrant stabilization of peripheral sensory dendrites. These findings establish a robust and amenable model for studying peripheral mechanisms of CIPN. Using this model,we uncovered a critical role for nicotinamide mononucleotide adenylyltransferase (Nmnat) in maintaining the integrity and function of peripheral sensory neurons and uncovered Nmnat's therapeutic potential against diverse sensory symptoms of CIPN.

KW - Chemotherapy

KW - Microtubules

KW - Neuropathy

KW - Neuroprotection

KW - Nmnat

KW - Paclitaxel

UR - http://www.scopus.com/inward/record.url?scp=85049015728&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85049015728&partnerID=8YFLogxK

U2 - 10.1242/dmm.032938

DO - 10.1242/dmm.032938

M3 - Article

C2 - 29716954

AN - SCOPUS:85049015728

VL - 11

JO - DMM Disease Models and Mechanisms

JF - DMM Disease Models and Mechanisms

SN - 1754-8403

IS - 6

M1 - dmm.032938

ER -